Overview

Treatment of Encopresis in Children With Autism Spectrum Disorders

Status:
Completed
Trial end date:
2022-11-17
Target enrollment:
0
Participant gender:
All
Summary
This study is comparing a multidisciplinary intervention for encopresis (MIE), consisting of both medical and behavioral components to treatment as usual control (TAU). Participants are first screened by a pediatric gastroenterologist and assessed and treated for any constipation or other potential medical complications. Following this, caregivers collect data on bowel movements and continence during a home baseline lasting no less than 14 days and no more than 21 days. Participants randomly assigned to treatment as usual or the treatment group, and begin attending daily appointments in clinic for 2 weeks. At appointments, the behavior team implements structured sits on the toilet to promote independent bowel movements (BMs). If an independent BM does not occur, the study team will administer a suppository to promote rapid release of the bowels and prompt the child to remain on the toilet following administration. In doing so, continent bowel movements are predictably evoked while the child is on the toilet, allowing for reinforcement with praise and preferred toys/activities. Eventually, suppositories are gradually decreased until the child is having BMs independently. Caregivers are trained to continue implementing the intervention following the clinic-based portion. The purpose of the current study is to evaluate MIE using a large randomized clinical trial (RCT), addressing the Department of Defense Autism Research Program, Area of Interest of Therapies to Alleviate Conditions Co-Occurring with autism spectrum disorder (ASD). The researchers will recruit 112 children diagnosed with ASD, randomizing them to two weeks of MIE, or treatment as usual (TAU) consisting of behavioral consultation and medical intervention. This study will evaluate MIE compared to TAU and determine the optimal treatment length.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Emory University
Collaborator:
United States Department of Defense
Treatments:
Glycerol
Criteria
Inclusion Criteria:

- Males and females from 5 years of age to 12 years 11 months of age.

- Diagnostic and Statistical Manual of Mental Disorders (DSM-5) diagnosis of Autism
Spectrum Disorder as established by clinical assessment, corroborated by the Autism
Diagnostic Observational Schedule, Autism Diagnostic Interview-Revised and/or
Childhood Autism Rating Scale-Second Edition.

- Fewer than 60% of days are continent days or more than 1 day out of 7 is an
incontinent day over the previous 7 days (a continent day is defined as a day with at
least one continent bowel movement. An incontinent day is a day with an incontinent
bowel movement regardless of whether a continent bowel movement also occurs).

- Medication free or on stable medication (no changes in past 6 weeks and no planned
changes for the next 6 months).

- Urine continent - Over half of the voids are continent when the child is with the
parent and when the child is on a typical toileting routine.

Exclusion Criteria:

- Presence of a known medical condition in the child (based on medical history or
physical examination) that would interfere with child's ability to control his/her
anus. These include: history of any anal surgery, spinal dysraphism (e.g., spina
bifida), other neurologic disorder affecting anal function, and prolonged/recurrent
gastrointestinal infectious disease (e.g. Clostridium difficile colitis). In addition,
the following may constitute exclusions following evaluation by a physician:
inflammatory bowel disease, short gut syndrome, chronic diarrhea, or history of
intestinal/abdominal surgery.

- Presence of a current serious behavioral problem or psychiatric condition that would
require another treatment (e.g., psychotic disorder, major depression, moderate or
greater aggression, severe disruptive behavior), based on information collected at
screening and the Behavior Problems Inventory-01 (BPI-01).

- Currently receiving and caregiver refusal to discontinue ongoing behavioral or
alternative medical intervention for encopresis.